This session will provide up to date and state of the art information on the treatment of cystic fibrosis, childhood interstitial lung disease, pulmonary vascular disease and viral infections including COVID.
CME credits and/or Certificates of Completion are not provided for this session.
1- Learn new findings about scientific developments in the field of childhood interstitial lung disease
2- Understand new findings about scientific developments in COVID research that have clinical relevance
3- Learn new findings about scientific developments in the field of cystic fibrosis that have clinical relevance
Eric D. Austin, MD, MSc: Update on Pulmonary Vascular Disease
Jennifer A. Wamback, MD, MS: Update on Childhood Interstitial Lung Disease
Mark Denison, MD: The Pediatric Impact of COVID Infection
Jessica E. Pittman, MD, MPH: Update on Cystic Fibrosis
You can save 20% today by joining the ATS.Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!